Compound ID | 1873
Synonym(s): AAI101 | OCID 5090 | 80VUN7L00C
Class: Beta-lactamase inhibitor
| Agent Type: | Semisynthetic; Small molecule; Antibiotic adjuvant; |
| Mechanism of action: | Irreversibly inhibits primarily Ambler class A serine β-lactamases (including CTX-M and many ESBLs) |
| Combined with other compounds: | Yes |
| Description: | Semisynthetic, derived from tazobactam, similar inhibition profiles to tazobactam; only available as a combination product, fixed combination with cefepime; penicillanic acid sulfone; no intrinsic antibacterial activity |
| Institute where first reported: | Orchid, Allecra |
| Year first mentioned: | 2008 |
| Highest development stage: | Approved by FDA in 2024 |
| Development status: | Approved |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/23653540 |
| Guide to Pharmacology: | enmetazobactam |
| Citations: |
|
| Patent: | US20080015156A1 |